Clinical Trial Update: A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above [Phase 3]

View source ↗

Summary

Phase 3 study evaluating safety and immune response of an RSV vaccine when given alone or together with an influenza vaccine in adults aged 65 and older; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Influenza vaccine (influenza vaccine)
• RSV vaccine (respiratory syncytial virus vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Respiratory Syncytial Virus Infections | Phase 3 | Status: COMPLETED | Results posted: 2024-04-04